Lexitas is a full-service ophthalmology CRO supporting biopharma and medical device clinical trials

Headquarters: Durham, NC
Status: Active
Industry: Clinical Trial Services –
Contract Research Organization
Investment Date: June 2022
Visit Site

Investment Thesis

Founder-owned and operated Lexitas reached an inflection point and partnered with QHP as a strategic capital partner to help execute on its growth strategy in the highly-fragmented global ophthalmic service provider market

QHP Value Enhancement